Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Regenxbio (RGNX) Return on Capital Employed (2016 - 2025)

Regenxbio has reported Return on Capital Employed over the past 11 years, most recently at 0.43% for Q4 2025.

  • Quarterly results put Return on Capital Employed at 0.43% for Q4 2025, up 16.0% from a year ago — trailing twelve months through Dec 2025 was 0.43% (up 16.0% YoY), and the annual figure for FY2025 was 0.47%, up 9.0%.
  • Return on Capital Employed for Q4 2025 was 0.43% at Regenxbio, down from 0.36% in the prior quarter.
  • Over the last five years, Return on Capital Employed for RGNX hit a ceiling of 0.19% in Q4 2021 and a floor of 0.6% in Q4 2024.
  • Median Return on Capital Employed over the past 5 years was 0.39% (2023), compared with a mean of 0.3%.
  • Biggest five-year swings in Return on Capital Employed: skyrocketed 43bps in 2022 and later tumbled -63bps in 2023.
  • Regenxbio's Return on Capital Employed stood at 0.19% in 2021, then plummeted by -287bps to 0.36% in 2022, then tumbled by -57bps to 0.57% in 2023, then decreased by -6bps to 0.6% in 2024, then increased by 28bps to 0.43% in 2025.
  • The last three reported values for Return on Capital Employed were 0.43% (Q4 2025), 0.36% (Q3 2025), and 0.4% (Q2 2025) per Business Quant data.